Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (694)
|
Core Tip (784)
|
Full Article (HTML) (2561)
|
Figures (1-1) (515)
|
Full Article (PDF)-1204K (218)
|
Full Article with Cover (PDF)-11949K (259)
|
Full Article (XML)-236K (140)
|
Audio-1342K (11)
|
Peer-Review Report-230K (151)
|
Answering Reviewers-97K (138)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (8087)
|
Similar Articles (78)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (733)
|
Core Tip (776)
|
Full Article (HTML) (1863)
|
Tables (1-1) (593)
|
Full Article (PDF)-358K (174)
|
Full Article with Cover (PDF)-11106K (236)
|
Full Article (XML)-54K (122)
|
Audio-1072K (14)
|
Peer-Review Report-236K (113)
|
Answering Reviewers-62K (110)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6577)
|
Similar Articles (21)
|
Timeline of Article Publication (1)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions
World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (838)
|
Core Tip (670)
|
Full Article (HTML) (7125)
|
Figures (1-2) (551)
|
Tables (1-5) (550)
|
Full Article (PDF)-1655K (300)
|
Full Article with Cover (PDF)-12399K (258)
|
Full Article (XML)-226K (147)
|
Audio-1259K (13)
|
Peer-Review Report-216K (130)
|
Answering Reviewers-145K (124)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (20)
|
Total Visits (12374)
|
Similar Articles (68)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (807)
|
Core Tip (726)
|
Full Article (HTML) (3891)
|
Figures (1-1) (548)
|
Full Article (PDF)-601K (299)
|
Full Article with Cover (PDF)-11346K (186)
|
Full Article (XML)-89K (136)
|
Audio-384K (14)
|
Peer-Review Report-180K (116)
|
Answering Reviewers-74K (131)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (24)
|
Total Visits (8704)
|
Similar Articles (345)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (776)
|
Core Tip (692)
|
Article Highlights (705)
|
Full Article (HTML) (2642)
|
Figures (1-4) (489)
|
Tables (1-3) (493)
|
Full Article (PDF)-1672K (189)
|
Full Article with Cover (PDF)-12418K (180)
|
Full Article (XML)-173K (119)
|
Audio-467K (8)
|
Peer-Review Report-182K (113)
|
Answering Reviewers-71K (147)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8953)
|
Similar Articles (2112)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (739)
|
Core Tip (750)
|
Article Highlights (859)
|
Full Article (HTML) (2275)
|
Figures (1-3) (567)
|
Tables (1-2) (531)
|
Full Article (PDF)-1874K (197)
|
Full Article with Cover (PDF)-12619K (214)
|
Full Article (XML)-114K (143)
|
Audio-386K (20)
|
Peer-Review Report-233K (135)
|
Answering Reviewers-161K (129)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (10521)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication
World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (652)
|
Core Tip (627)
|
Article Highlights (694)
|
Full Article (HTML) (1644)
|
Figures (1-4) (473)
|
Full Article (PDF)-5746K (177)
|
Full Article with Cover (PDF)-16492K (174)
|
Full Article (XML)-96K (131)
|
Audio-3997K (11)
|
Peer-Review Report-192K (116)
|
Answering Reviewers-146K (129)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7195)
|
Similar Articles (43)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (727)
|
Core Tip (706)
|
Article Highlights (771)
|
Full Article (HTML) (2829)
|
Figures (1-4) (466)
|
Tables (1-5) (495)
|
Full Article (PDF)-6006K (211)
|
Full Article with Cover (PDF)-16750K (208)
|
Full Article (XML)-200K (123)
|
Audio-376K (9)
|
Peer-Review Report-182K (132)
|
Answering Reviewers-60K (134)
|
Supplementary Material-355K (126)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (11244)
|
Similar Articles (1955)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (658)
|
Core Tip (722)
|
Article Highlights (711)
|
Full Article (HTML) (1996)
|
Figures (1-4) (500)
|
Tables (1-4) (489)
|
Full Article (PDF)-5941K (182)
|
Full Article with Cover (PDF)-16687K (191)
|
Full Article (XML)-115K (130)
|
Audio-187K (10)
|
Peer-Review Report-215K (127)
|
Answering Reviewers-37K (140)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (8814)
|
Similar Articles (2622)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (696)
|
Core Tip (716)
|
Full Article (HTML) (1767)
|
Figures (1-1) (547)
|
Full Article (PDF)-5068K (204)
|
Full Article with Cover (PDF)-15813K (176)
|
Full Article (XML)-63K (123)
|
Audio-811K (4)
|
Peer-Review Report-266K (132)
|
Answering Reviewers-225K (130)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7557)
|
Similar Articles (4469)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (696)
|
Core Tip (747)
|
Full Article (HTML) (1741)
|
Full Article (PDF)-325K (151)
|
Full Article with Cover (PDF)-11079K (180)
|
Full Article (XML)-24K (128)
|
Audio-243K (4)
|
Peer-Review Report-215K (101)
|
Answering Reviewers-19K (106)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5435)
|
Similar Articles (404)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
